Episode 58: Preventing Non-Adherence with Dr. Josh Benner, founder of RxAnte
August 27, 201538:45

Episode 58: Preventing Non-Adherence with Dr. Josh Benner, founder of RxAnte

Joshua Benner, PharmD, ScD, is the Founder of RxAnte, a provider of science-based information technology solutions for improving quality and lowering the cost of healthcare.

In August 2014, Dr. Benner was named the Executive Vice President of Strategy and Corporate Development for RxAnte’s parent company, Millennium Health.

A leading voice on medication adherence, Dr. Benner’s award-winning research and numerous publications have shed new light on the problem of nonadherence and identified promising approaches to improving it. Prior to RxAnte, Dr. Benner was Fellow and Managing Director at the Brookings Institution’s Engelberg Center for Health Care Reform, where he focused on medical technology policy. Prior to Brookings, Dr. Benner was principal at ValueMedics Research, an analytic and consulting services firm. Following the successful sale of ValueMedics to IMS Health in 2007, he served as senior principal in health economics and outcomes research and global lead for medication adherence at IMS. Dr. Benner received his Doctor of Pharmacy degree from Drake University and his Doctor of Science in health policy and management from the Harvard University School of Public Health. He remains a Visiting Scholar in Economic Studies at Brookings, and is an adjunct scholar in Clinical Epidemiology and Biostatistics at the University of Pennsylvania School of Medicine.

Social Handles:

LinkedIn: https://www.linkedin.com/company/rxante-inc-

Twitter: https://x.com/rxante

Facebook: https://www.facebook.com/RxAnte


00:00 Josh explains what RxAnte is, and why he founded it.
02:00 How Underuse, Overuse, and Misuse of prescription drugs is costing Americans $300 Billion a year.
03:15 RxAnte’s approach to fixing the adherence problem and preventing underuse of prescription medication
06:00 RxAnte’s approach to identify patients at risk of underusing their prescription medications.
06:45 How Real-Time prescription data allows providers to open up a conversation about adherence with their patients.
08:40 How Value-Based reimbursement is benefiting medication use as well.
09:00 How RxAnte predicts which patients will stop using their prescription medications too soon.
11:35 How RxAnte screens for patients who might stop using prescription medication due to its side effects.
14:15 RxAnte factors in types of prescription medication prescribed, and known side effects for those drugs.
17:00 RxAnte uses data to not only identify at-risk patients, but also help providers prescribe more accurately to proactively prevent adherence issues.
18:30 The steps by which RxAnte establishes their services, once hired.
19:20 Who hires RxAnte, and why.
22:15 What is RxEffect and how it works.
24:40 Population Health Nurses and the growing popularity of this occupation.
26:00 Why providers are choosing RxAnte.
28:00 The problem with the typical “P for P” system.
34:00 Where RxAnte’s services begin for patients at risk of overdosing on medication, particularly unsafe use of pain medications.
37:50 You can find out more information at www.RxAnte.com.

healthcare,health,patient,medication,provider,adherence,healthIT,Prescription,rxante,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, Steven Elkins, Matthew Bunte, Lori Smith, Dr. Scott Conard, Vivian Ho and Casey Cormier

Recent Episodes

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD
Relentless Health ValueNovember 04, 2026
536
37:5134.64 MB

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD

Listen On Your Favorite App Stacey: If you are a plan sponsor thinking about, for example, primary care as a way to optimize healthcare spend, do know that any given plan sponsor will really only get maximum possible benefit from an investment in primary care, advanced primary care, when and only wh...

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone
Relentless Health ValueOctober 28, 2026
535
37:1834.15 MB

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone

LIsten on Your Favorite App On episode 532 a few weeks ago, Chris Klomp from HHS was talking about ER (emergency room) usage as a signal, not just a statistic. If too many folks show up in the ER, consider this a signal that there's something missing. It means a patient who doesn't have access to pr...

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson
Relentless Health ValueOctober 21, 202608:538.13 MB

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson

Listen On Your Favorite App Here's a question I have heard more than once: What is a practical, speedy way to assess whether a TPA (third-party administrator) is truly independent and willing to protect the plan's interests, this plan sponsor's interests, versus being captive to, for example, networ...

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.